Shining the spotlight on Breakthrough T1D scientist Dr. Cassandra Bazile
Dr. Cassandra Bazile is a scientist at Breakthrough T1D who champions community, mentorship, and inclusion in STEM.
Letter from Aaron J. Kowalski, PhD, CEO of Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes research and advocacy organization, to Robert F. Kennedy Jr., United States Secretary of Health and Human Services (HHS)
Dear Secretary Kennedy, Congratulations on your confirmation as United States Secretary of Health and Human Services. On behalf of the…
Improving lives through clinical trials
Marjorie Lazarre has seen the life-changing outcomes of T1D research and is confident clinical trials are the path to cures.
A behind-the-scenes look at DIAGNODE-3: Phase 3 clinical trials of Diamyd® for T1D
DIAGNODE-3 is a phase 3 clinical trial of the disease-modifying therapy Diamyd® that aims to preserve insulin-producing beta cells.
When to call it type 1 diabetes
Learn about the different types of diabetes, including LADA and gestational diabetes, and which are classified as type 1 diabetes.
The extraordinary contributions of African Americans to healthcare
Join Breakthrough T1D in honoring African American pioneers who have made significant contributions to research, science, and healthcare.
Buffalo Bills fans rally around Mark Andrews and Breakthrough T1D
Buffalo Bills fans turned negativity into philanthropy by donating to Breakthrough T1D, chosen charity of the Baltimore Ravens' Mark Andrews.
Cell therapies 101: What are stem cells and why do they matter?
Researchers are harnessing the power of stem cells to generate functional beta cells and islets, driving us closer toward type…
Cell therapy first: transplanted islets working without immunosuppressives
Today, Sana Biotechnology released significant clinical data: the first person with type 1 diabetes (T1D) who received deceased donor islets…
2024 greatest T1D hits: A glance at this year’s achievements
While we look back on 2024, we can reflect upon the incredible progress we’ve made in advancing breakthroughs toward cures…
